Cardiomyopathy primary prevention

Revision as of 20:35, 25 June 2019 by Lina Yaqoub (talk | contribs)
Jump to navigation Jump to search

Cardiomyopathy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Cardiomyopathy from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Guidelines

2023 ESC Guideline Recommendations

2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy

Case Studies

Case #1

Cardiomyopathy primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Cardiomyopathy primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Cardiomyopathy primary prevention

CDC on Cardiomyopathy primary prevention

Cardiomyopathy primary prevention in the news

Blogs on Cardiomyopathy primary prevention

Directions to Hospitals Treating Cardiomyopathy

Risk calculators and risk factors for Cardiomyopathy primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Lina Ya'qoub, MD

Overview

Methods of primary prevention for cardiomyopathy include; maintaining a healthy weight, not smoking, avoiding alcohol and illicit drugs, reducing stress, and treating underlying conditions such as diabetes and high blood pressure. Also, those patients with cardiomyopathy with high risk features for sudden cardiac death are usually referred for implantable cardioverter defibrillator (ICD) placement for primary prevention.

Primary Prevention

Methods of primary prevention for cardiomyopathy include; maintaining a healthy weight, not smoking, avoiding alcohol and illicit drugs, reducing stress, and treating underlying conditions such as diabetes and high blood pressure:[1][2]

  • Quitting smoking
  • Losing excess weight
  • Avoiding the use of alcohol and illegal drugs
  • Getting enough sleep and rest
  • Reducing stress
  • Treating underlying conditions, such as diabetes and high blood pressure
  • ICD placement for patients at high risk for sudden cardiac death

References

  1. Al-Khatib SM, Fonarow GC, Joglar JA, Inoue L, Mark DB, Lee KL, Kadish A, Bardy G, Sanders GD (June 2017). "Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy: A Meta-analysis". JAMA Cardiol. 2 (6): 685–688. doi:10.1001/jamacardio.2017.0630. PMID 28355432. Vancouver style error: initials (help)
  2. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH (May 2004). "Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy". N. Engl. J. Med. 350 (21): 2151–8. doi:10.1056/NEJMoa033088. PMID 15152060.

Template:WS